Xiao-Xia Zhang1, Qiao-Feng Wu2, Yun-Liang Yan1, Feng-Ling Zhang1. 1. College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China. 2. College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China. wqfyjm@sina.com.
Abstract
OBJECTIVE: The Shixiangru (Mosla chinensis Maxim) total flavonoids (STF) mainly contain luteolin and apigenin. The study aims to examine the inhibitory effects of STF on anti-H1N1 influenza virus and its related molecular mechanisms in pneumonia mice. METHODS: The viral pneumonia mice were treated with Ribavirin or various doses of STF. We observed histological changes of lung by immunohistochemistry and measured lung index to value anti-influenza virus effects of STF. The concentrations of inflammatory cytokines and anti-oxidant factors were detected by ELISA. RT-PCR and western blot assays were used to determine the expression level of TLR pathway's key genes and proteins in lung tissues. RESULTS: We found that the pathological changes of lung in the viral pneumonia mice obviously alleviated by STF treatments and the STF (288 or 576 mg/kg) could significantly decrease lung indices. Moreover, the up-regulation (IL-6, TNF-α, IFN-γ, and NO) and down-regulation (IL-2, SOD and GSH) of inflammatory cytokines and anti-oxidant factors were associated with higher clearance of virus and reduction of inflammatory lung tissue damage. Meanwhile, the expression levels of TLR3, TLR7, MyD88, TRAF3 and NF-κB p65 of the TLR pathway were reduced by STF treatment. CONCLUSIONS: This study suggested that STF may be a promising candidate for treating H1N1 influenza and subsequent viral pneumonia.
OBJECTIVE: The Shixiangru (Mosla chinensis Maxim) total flavonoids (STF) mainly contain luteolin and apigenin. The study aims to examine the inhibitory effects of STF on anti-H1N1influenza virus and its related molecular mechanisms in pneumoniamice. METHODS: The viral pneumoniamice were treated with Ribavirin or various doses of STF. We observed histological changes of lung by immunohistochemistry and measured lung index to value anti-influenza virus effects of STF. The concentrations of inflammatory cytokines and anti-oxidant factors were detected by ELISA. RT-PCR and western blot assays were used to determine the expression level of TLR pathway's key genes and proteins in lung tissues. RESULTS: We found that the pathological changes of lung in the viral pneumoniamice obviously alleviated by STF treatments and the STF (288 or 576 mg/kg) could significantly decrease lung indices. Moreover, the up-regulation (IL-6, TNF-α, IFN-γ, and NO) and down-regulation (IL-2, SOD and GSH) of inflammatory cytokines and anti-oxidant factors were associated with higher clearance of virus and reduction of inflammatory lung tissue damage. Meanwhile, the expression levels of TLR3, TLR7, MyD88, TRAF3 and NF-κB p65 of the TLR pathway were reduced by STF treatment. CONCLUSIONS: This study suggested that STF may be a promising candidate for treating H1N1influenza and subsequent viral pneumonia.
Authors: Paola M Barral; Devanand Sarkar; Zao-zhong Su; Glen N Barber; Rob DeSalle; Vincent R Racaniello; Paul B Fisher Journal: Pharmacol Ther Date: 2009-07-15 Impact factor: 12.310
Authors: Meredith L Heltzer; Susan E Coffin; Kelly Maurer; Asen Bagashev; Zhe Zhang; Jordan S Orange; Kathleen E Sullivan Journal: J Leukoc Biol Date: 2009-06 Impact factor: 4.962
Authors: Ilwoong Hwang; Jeannine M Scott; Tejaswi Kakarla; David M Duriancik; Seohyun Choi; Chunghwan Cho; Taehyung Lee; Hyojin Park; Anthony R French; Eleni Beli; Elizabeth Gardner; Sungjin Kim Journal: PLoS One Date: 2012-12-31 Impact factor: 3.240
Authors: Parteek Prasher; Mousmee Sharma; Meenu Mehta; Keshav R Paudel; Saurabh Satija; Dinesh K Chellappan; Harish Dureja; Gaurav Gupta; Murtaza M Tambuwala; Poonam Negi; Peter R Wich; Nicole G Hansbro; Philip M Hansbro; Kamal Dua Journal: Chem Biol Interact Date: 2020-05-04 Impact factor: 5.192